Project description
Harnessing the power of the smallest to transform healthcare
In the world of the human microbiome, Archaea (the ‘third domain of life’) remain largely uncharted territory. Beside bacteria and fungi, Archaea have been described as a stable component of the human microbiome. The ERC-funded ArcHealth project seeks to expand the related narrative. With only a few Archaea isolated from humans to date, ArcHealth aims to harness these elusive microorganisms. Their breakthrough achievement is the cultivation of Archaea for medical use. This groundbreaking research promises a paradigm shift in treatment standards, offering sustainable, safe and beneficial solutions derived from our own bodies. ArcHealth paves the way for a new era of personalised medicine.
Objective
"Beside Bacteria and fungi, Archaea, the ""third domain of life"" have been described as a stable component of the human microbiome. Yet, only few archaea have so far been isolated from humans.
The project aims to demonstrate that a fundamentally new product, derived from archaea, revolutionizing current standards of treatments for human health, can be developed from our initial breakthrough achievement, the cultivation of these archaea. The benefits of using archaea derived from human bodies, promise a sustainable, safe and beneficial treatment in the future."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
You need to log in or register to use this function
Programme(s)
- HORIZON.1.1 - European Research Council (ERC) Main Programme
Funding Scheme
HORIZON-ERC-POC - HORIZON ERC Proof of Concept GrantsHost institution
1010 Wien
Austria